Pretransplant low CD3+CD25high cell counts or a low CD3+CD25high/CD3+HLA-DR+ ratio are associated with an increased risk to acute renal allograft rejection

Transplantation

Volumn 92, Issue 5, 2011, Pages 536-542

  Hueso, Miguel ^a   Mestre, Mariona ^a   Benavente, Yolanda ^b,c   Bas, Jordi ^a   Grinyó, Josep M ^a   Navarro, Estanislau ^d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Bellvitge Biomedical Research Institute   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

CD3 +CD25high cells; CD3+CD25high CD3+HLA DR+ ratio; Kidney allograft rejection; Pretransplant risk assessment

Indexed keywords

CD134 ANTIGEN; CYCLOSPORIN; HERMES ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD3+ CD25+ T LYMPHOCYTE; CD3+ CD25+ T LYMPHOCYTE CD3+ HLA DR+ T LYMPHOCYTE RATIO; CD3+ CD25+ T LYMPHOCYTE COUNT; CD3+ HLA DR+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; PATIENT IDENTIFICATION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTORS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 80052417634     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182283c58     Document Type: Article

References (37)

1. Sakaguchi S. Naturally arising CD4+regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531.
2. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
3. Kingsley CI, Karim M, Bushell AR, et al. CD25+CD4+regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080.
4. Womer KL, Huang Y, Herren H, et al. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. Transplantation 2010; 89: 115.
5. Bestard O, Cruzado JM, Mestre M, et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007; 179: 4901.
6. Han F, Lv R, Jin J, et al. Pre-transplant serum concentrations of antiendothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection. Clin Chem Lab Med 2009; 47: 1265.
7. Rotondi M, Rosati A, Buonamano A, et al. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 2004; 4: 1466.
8. Brouard S, Soulillou JP. Pre-transplant serum level of CXCL9 as a biomarker of acute rejection and graft failure risk in kidney transplantation. Transpl Int 2010; 23: 461.
9. Rotondi M, Netti GS, Lazzeri E, et al. High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. Transpl Int 2010; 23: 465.
10. Rouschop KM, Roelofs JJ, Rowshani AT, et al. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. Nephrol Dial Transplant 2005; 20: 2248.
11. Pelzl S, Opelz G, Wiesel M, et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation 2002; 73: 3.
12. Susal C, Pelzl S, Dohler B, et al. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 2002; 13: 1650.
13. Kim MS, Kim HJ, Kim SI, et al. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation. Transplantation 2006; 82: 1602.
14. Slavcev A, Lacha J, Honsova E, et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 2005; 14: 117.
15. Demirci G, Amanullah F, Kewalaramani R, et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol 2004; 172: 1691.
16. Kirveskari J, Paavonen T, Hayry P, et al. De novo induction of endothelial L-selectin ligands during kidney allograft rejection. J Am Soc Nephrol 2000; 11: 2358.
17. Nadal E, Garin M, Kaeda J, et al. Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2007; 21: 472.
18. Sawitzki B, Schlickeiser S, Reinke P, et al. Pretransplant immune risk assessment. Curr Opin Organ Transplant 2009; 14: 650.
19. Susal C, Pelzl S, Simon T, et al. Advances in pre-and posttransplant immunologic testing in kidney transplantation. Transplant Proc 2004; 36: 29.
20. Sagoo P, Lombardi G, Lechler RI. Regulatory T cells as therapeutic cells. Curr Opin Organ Transplant 2008; 13: 645.
21. Safinia N, Sagoo P, Lechler R, et al. Adoptive regulatory T cell therapy: Challenges in clinical transplantation. Curr Opin Organ Transplant 2010; 15: 427.
22. Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257.
23. Klein S, Kretz CC, Krammer PH, et al. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol 2010; 130: 492.
24. Kleinewietfeld M, Starke M, Di Mitri D, et al. CD49d provides access to "untouched" human Foxp3+Treg free of contaminating effector cells. Blood 2009; 113: 827.
25. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+regulatory T cells. Blood 2005; 105: 4743.
26. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 12: 277.
27. Bushell A, Karim M, Kingsley CI, et al. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+regulatory T cells: A potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
28. Cavinato RA, Casiraghi F, Azzollini N, et al. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 2005; 79: 1034.
29. Stenard F, Nguyen C, Cox K, et al. Decreases in circulating CD4 CD25hiFOXP3+cells and increases in intragraft FOXP3+cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009; 13: 70.
30. Karczewski J, Karczewski M, Wiktorowicz K. Possible defect of T suppressor cell subpopulation in patients with kidney acute rejection. Transplant Proc 2010; 42: 4538.
31. Batsford S, Dickenmann M, Durmuller U, et al. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful? Clin Nephrol 2011; 75: 101.
32. Huang Y, Shan J, Zhang C, et al. Peripheral blood T regulatory cell counts may not predict transplant rejection. BMC Immunol 2010; 11: 40.
33. Kollins D, Stoelcker B, Hoffmann U, et al. FOXP3+regulatory T-cells in renal allografts: Correlation with long-term graft function and acute rejection. Clin Nephrol 2010; 75: 91.
34. Bienvenu B, Martin B, Auffray C, et al. Peripheral CD8+CD25+T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 2005; 175: 246.
35. Maggi E, Cosmi L, Liotta F, et al. Thymic regulatory T cells. Autoimmun Rev 2005; 4: 579.
36. Vu MD, Clarkson MR, Yagita H, et al. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 2006; 176: 1394.
37. Bas J, Mestre M, Grinyo JM, et al. Peripheral blood lymphoid subsets and long-term clinical course of kidney recipients: A longitudinal study. Cytometry 1998; 34: 103.